查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825963

2025年数​​位化糖尿病管理全球市场报告

Digital Diabetes Management Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，数位化糖尿病管理市场规模呈指数级增长，从2024年的159亿美元增长到2025年的191.9亿美元，复合年增长率达20.7%。预测期内的成长归因于糖尿病盛行率的上升、技术进步、个人化医疗、监管支援、远端保健和远端监控。

预计未来几年，数位化糖尿病管理市场将呈指数级增长，到2029年将达到466.8亿美元，复合年增长率为24.9%。预测期内的成长归因于持续的糖尿病流行、人工智慧 (AI) 和机器学习、数据整合以及远端护理模式。预测期内的主要趋势包括持续血糖监测 (CGM)、胰岛素输送系统、行动应用程式和穿戴式装置以及病人参与和教育。

数位化糖尿病管理是指利用电子医疗解决方案远端监测、分析和监督糖尿病患者及糖尿病高风险族群的健康状况。数位化糖尿病管理使人们能够有效地自我管理糖尿病，并改善健康状况。

数位糖尿病管理产品和服务的主要类别包括设备、应用程式、资料管理软体、平台和服务。资料管理平台 (DMP) 是一种用于收集和管理资料的软体工具，使公司能够创建不同的受众细分，从而在线上广告宣传中定位特定个人和偏好。各种类型的设备，包括手持设备和穿戴式设备，应用于各个领域，例如自我保健、家庭保健、医院、糖尿病诊所和其他医疗保健场所。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供数位化糖尿病管理市场统计数据，例如全球市场规模、区域份额、数位化糖尿病管理市场份额的竞争对手、详细的数位化糖尿病管理细分市场、市场趋势和机会，以及您在数位化糖尿病管理行业取得成功所需的数据。本数位化糖尿病管理市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

预测的五年成长率为24.9%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的糖尿病治疗，因为这将提高从瑞士和爱尔兰进口的连续血糖监测仪 (CGM) 和胰岛素帮浦组件的成本，这可能会恶化血糖控制并增加内分泌诊所的费用。由于互惠关税以及不断升级的贸易摩擦和贸易限制对全球经济和贸易的负面影响，其影响也将更加广泛。

糖尿病盛行率的不断上升预计将推动对数位化糖尿病管理设备及相关服务的需求，从而扩大市场需求。糖尿病是导致死亡的主要原因之一，30%的预期寿命缩短归因于糖尿病诊断。例如，英国政府机构NHS England在2024年6月报告称，40岁以下面临2型糖尿病风险的人数将增加近25%，从2022年的173,166人增加到2023年的216,440人。糖尿病盛行率的上升刺激了对数位化糖尿病管理解决方案的需求。

预计不断增长的医疗保健支出将推动数位化糖尿病管理市场的成长。医疗保健支出涵盖特定时期内个人、社区、国家或全球层面在医疗保健相关服务、产品和活动上的总支出。医疗保健支出的增加，加上医疗服务可近性的改善和糖尿病诊断数量的增加，导致研发投入增加。这将推动数位化和先进糖尿病护理设备的进步，例如增强型血糖监测系统、胰岛素输送设备和数位化健康解决方案。例如，英国国家统计局报告称，2022 年英国的医疗保健支出将达到约 3,548.8 亿美元（2,830 亿英镑），比上一年名义增加 0.7%。因此，预计不断增长的医疗保健支出将在未来几年推动数位化糖尿病管理市场的成长。

随着越来越多的公司专注于设计基于人工智慧的互联应用以提升用户体验，数位化糖尿病管理市场正日益受到青睐。 OneDrop、Ascencia 和 Dario 等该市场的知名公司正将重点转向打造时尚产品，而非传统的医疗设备。例如，美敦力公司 (Medtronic plc) 和 IBM Watson Health 最近推出了一款基于人工智慧的智慧糖尿病管理应用程式 Sugar.IQ。

主要企业也正在推出创新产品以增强其竞争地位。 Dexcom ONE 连续血糖监测系统是一种使用者友好的即时连续血糖监测解决方案，无需痛苦的手指刺穿。例如，2022 年 4 月，专门从事连续血糖监测系统的美国公司 DexCom 推出了 Dexcom ONE 连续血糖监测系统。这种即时 CGM 旨在使其更具成本效益并让英国糖尿病患者更容易获得，目前正在接受纳入英国区域药品定价系统的审查。 Dexcom ONE 系统由穿戴式感测器和发射器组成，提供连续血糖监测，并透过使用者友好的 Dexcom ONE 行动应用程式将即时资料传输到相容的智慧型装置。这项技术无需痛苦的手指刺破，并为明智的治疗决策提供趋势箭头和可自订的警报，以防止危险的血糖波动。

2023年5月，总部位于爱尔兰的医疗科技公司美敦力（Medtronic PLC）以7.38亿美元收购了EOFLOW。此次收购将使Medtronic能够将其无管设备与连续血糖监测仪和膳食检测演算法相结合，建立一个先进的闭合迴路系统，以实现更自动化的糖尿病管理。 EOFLOW是一家总部位于韩国的数位化、智慧化和穿戴式糖尿病管理解决方案提供商。

数位糖尿病管理市场的主要企业包括拜耳股份公司、美敦力公司、罗氏诊断有限公司、Dexcom Inc.、雅培实验室、Ascensia Diabetes Care Holdings AG、Insulet Corporation、B. Braun Melsungen AG、Tandem Diabetes Care Inc.、LifeScan Inc.、AgaMatrix Inc.、Glooko Inc.D., Glooko Inc. Inc、ACON Laboratories Inc.、Becton, Dickinson and Company、Care Innovations LLC、Health2Sync Inc.、Emperra GmbH E-Health Technologies、Azumio Inc.、Decide Clinical Software GmbH、pendiq GmbH Moers、Health Arx Technologies Pvt Ltd。 Ltd. 等。

2024年，数位化糖尿病管理市场最大的地区是北美。西欧是数位化糖尿病管理市场报告涵盖的第二大地区。数位化糖尿病管理市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

数位糖尿病管理市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。

数位糖尿病管理市场由提供血糖管理设备和服务的公司收益，这些设备和服务用于管理人体血糖值。这些设备在糖尿病患者的照护中发挥关键作用，帮助他们管理血糖值并控制病情。该市场的价值是指出厂价，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球数位化糖尿病管理：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球数位糖尿病管理市场：增长率分析
  • 全球数位糖尿病管理市场表现：规模与成长，2019-2024
  • 全球数位糖尿病管理市场预测：规模与成长，2024-2029 年，2034 年
  • 全球数位糖尿病管理：总目标市场（TAM）

第六章 市场细分

  • 全球数位糖尿病管理市场（按产品和服务划分）、实际和预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 装置
  • 应用
  • 资料管理软体和平台
  • 服务
  • 全球数位糖尿病管理市场（按设备类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 手持装置
  • 穿戴式装置
  • 全球数位糖尿病管理市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 自我护理和家庭保健
  • 医院和糖尿病诊所
  • 其他最终用户
  • 全球数位糖尿病管理市场：按设备（类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 连续血糖监测仪（CGM）
  • 血糖仪（BGM）
  • 胰岛素帮浦
  • 智慧胰岛素笔
  • 糖尿病试纸
  • 全球数位糖尿病管理市场：按应用程式（类型）细分、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 糖尿病管理应用程式
  • 生活方式和饮食管理应用程式
  • 血糖值追踪应用程式
  • 胰岛素剂量调整应用程式
  • 锻炼和活动追踪应用程式
  • 全球数位糖尿病管理市场：按资料管理软体和平台细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 云端基础的糖尿病管理平台
  • 数据分析平台
  • 电子健康记录（EHR）整合系统
  • 病人管理软体
  • 远端监控软体
  • 全球数位糖尿病管理市场：依服务类型细分，实质及预测，2019-2024 年、2024-2029 年、2034 年
  • 远端医疗和虚拟咨询服务
  • 远端监控服务
  • 糖尿病教育服务
  • 糖尿病指导与支持服务
  • 临床决策支援服务

第七章 区域和国家分析

  • 全球数位糖尿病管理市场：区域分析、预测与趋势，2019-2024 年、2024-2029 年、2034 年
  • 全球数位糖尿病管理市场：国家、现况及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 数位糖尿病管理市场：竞争格局
  • 数位糖尿病管理市场：公司简介
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Ascensia Diabetes Care Holdings AG
  • Insulet Corporation
  • B. Braun Melsungen AG
  • Tandem Diabetes Care Inc.
  • LifeScan Inc.
  • AgaMatrix Inc.
  • Glooko Inc.
  • DarioHealth Corp
  • One Drop
  • Dottli Oy
  • Ypsomed Holding AG
  • ARKRAY Inc.
  • ACON Laboratories Inc.
  • Becton, Dickinson and Company
  • Care Innovations LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年数位糖尿病管理市场：提供新机会的国家
  • 2029 年数位糖尿病管理市场：细分市场将带来新机会
  • 2029 年数位糖尿病管理市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32495u

Digital diabetes management involves the utilization of electronic healthcare solutions to remotely monitor, analyze, and oversee the well-being of individuals with diabetes or those at risk of developing the condition. Through the use of digital diabetes management, people can enhance their health outcomes by effectively self-managing their diabetes.

The primary categories of products and services within the field of digital diabetes management encompass devices, applications, data management software, and platforms, as well as various services. A data management platform (DMP) serves as a software tool for collecting and managing data, enabling companies to create distinct audience segments that can be leveraged to target specific individuals and settings in online advertising campaigns. Various device types, including handheld and wearable devices, find application across different sectors such as self or home healthcare, hospitals, specialty diabetes clinics, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The digital diabetes management market research report is one of a series of new reports from The Business Research Company that provides digital diabetes management market statistics, including digital diabetes management industry global market size, regional shares, competitors with a digital diabetes management market share, detailed digital diabetes management market segments, market trends and opportunities, and any further data you may need to thrive in the digital diabetes management industry. This digital diabetes management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital diabetes management market size has grown exponentially in recent years. It will grow from $15.9 billion in 2024 to $19.19 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to rising diabetes prevalence, technological advancements, personalized healthcare, regulatory support, telehealth and remote monitoring.

The digital diabetes management market size is expected to see exponential growth in the next few years. It will grow to $46.68 billion in 2029 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to continued diabetes epidemic, artificial intelligence (AI) and machine learning, data integration, remote care models. Major trends in the forecast period include continuous glucose monitoring (cgm), insulin delivery systems, mobile apps and wearables, patient engagement and education.

The forecast of 24.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. diabetes care by raising costs for continuous glucose monitors (CGMs) and insulin pump components imported from Switzerland and Ireland, potentially worsening glycemic control and increasing endocrinology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the demand for digital diabetes management devices and associated services, thereby increasing the market's demand. Diabetes is a leading cause of death, with 30% of the reduction in life expectancy attributed to diabetes diagnosis. For example, in June 2024, the NHS England, a UK-based government agency, reported a nearly 25% increase in the number of individuals under the age of 40 at risk of type 2 diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This growing prevalence of diabetes is fueling the demand for digital diabetes management solutions.

The rise in healthcare expenditures is predicted to fuel the growth of the digital diabetes management market. Healthcare expenditures encompass the total amount spent on healthcare-related services, products, and activities within a specified period, whether at an individual, community, national, or global level. The increased healthcare spending, combined with improved access to healthcare services and a growing number of diabetes diagnoses, leads to greater investments in research and development. This, in turn, results in the advancement of digital and advanced diabetes care devices, such as enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in 2022, the Office for National Statistics reported that UK healthcare spending reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to the previous year. As a result, the rising healthcare expenditure is expected to drive the growth of the digital diabetes management market in the coming years.

Several companies are placing increasing emphasis on designing AI-powered connected apps to enhance the user experience, a trend gaining significant popularity in the digital diabetes management market. Prominent companies in this market, such as OneDrop, Ascencia, and Dario, are shifting their focus towards making their products appear more like stylish gadgets rather than traditional medical devices. As an example, Medtronic plc and IBM Watson Health recently introduced the AI-powered Sugar.IQ smart diabetes management app, designed to simplify and enhance daily diabetes management.

Key players in the digital diabetes management market are also introducing innovative products to gain a competitive edge. The Dexcom ONE Continuous Glucose Monitoring System is a user-friendly, real-time continuous glucose monitoring solution that eliminates the need for painful fingerpricks. For instance, in April 2022, DexCom, Inc., a US-based company specializing in continuous glucose monitoring systems, launched the Dexcom ONE Continuous Glucose Monitoring System. This real-time CGM aims to be more cost-effective and accessible for individuals with diabetes in the UK and is currently undergoing review for inclusion in UK regional drug tariffs. The Dexcom ONE system, comprising a wearable sensor and transmitter, offers continuous glucose monitoring and sends real-time data to a compatible smart device through the user-friendly Dexcom ONE mobile app. This technology eliminates the need for painful fingerpricks and provides trend arrows for informed treatment decisions, along with customizable alerts to prevent dangerous glucose fluctuations.

In May 2023, Medtronic PLC, an Ireland-based medical technology company, acquired EOFLOW Co., Ltd. for $738 million. This acquisition enables Medtronic to establish an advanced closed-loop system for more automated diabetes management by combining tubeless devices with their continuous glucose monitors and meal-detection algorithm. EOFLOW Co., Ltd. is a South Korea-based provider of digital and smart wearable diabetes management solutions.

Major companies operating in the digital diabetes management market include Bayer AG, Medtronic PLC, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.

North America was the largest region in the digital diabetes management market in 2024. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the digital diabetes management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The digital diabetes management market consists of revenue generated by the companies offering devices and services that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patients' blood glucose levels and controlling their conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Diabetes Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital diabetes management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital diabetes management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital diabetes management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Devices; Application; Data Management Software And Platforms; Services
  • 2) By Device Type: Handheld Devices; Wearable Devices
  • 3) By End User: Self Or Home Healthcare; Hospitals And Specialty Diabetes Clinics; Other End Users
  • Subsegments:
  • 1) By Devices: Continuous Glucose Monitors (CGMs); Blood Glucose Meters (BGM); Insulin Pumps; Smart Insulin Pens; Diabetes Testing Strips
  • 2) By Application: Diabetes Management Apps; Lifestyle And Diet Management Apps; Glucose Tracking Apps; Insulin Dose Adjustment Apps; Exercise And Activity Tracking Apps
  • 3) By Data Management Software And Platforms: Cloud-Based Diabetes Management Platforms; Data Analytics Platforms; Electronic Health Record (EHR) Integrated Systems; Patient Management Software; Remote Monitoring Software
  • 4) By Services: Telemedicine And Virtual Consultation Services; Remote Monitoring Services; Diabetes Education Services; Diabetes Coaching And Support Services; Clinical Decision Support Services
  • Companies Mentioned: Bayer AG; Medtronic Plc; Roche Diagnostics Ltd.; Dexcom Inc.; Abbott Laboratories; Ascensia Diabetes Care Holdings AG; Insulet Corporation; B. Braun Melsungen AG; Tandem Diabetes Care Inc.; LifeScan Inc.; AgaMatrix Inc.; Glooko Inc.; DarioHealth Corp; One Drop; Dottli Oy; Ypsomed Holding AG; ARKRAY Inc.; ACON Laboratories Inc.; Becton, Dickinson and Company; Care Innovations LLC; Health2Sync Inc.; Emperra GmbH E-Health Technologies; Azumio Inc.; Decide Clinical Software GmbH; pendiq GmbH Moers; Health Arx Technologies Pvt Ltd.; Sanofi SA; Johnson & Johnson Co; Novo Nordisk AS; Terumo Corporation; TidePool; AgaMatrix Medical Devices Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Diabetes Management Market Characteristics

3. Digital Diabetes Management Market Trends And Strategies

4. Digital Diabetes Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Diabetes Management Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Digital Diabetes Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Digital Diabetes Management Market Growth Rate Analysis
  • 5.4. Global Digital Diabetes Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Digital Diabetes Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Digital Diabetes Management Total Addressable Market (TAM)

6. Digital Diabetes Management Market Segmentation

  • 6.1. Global Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Application
  • Data Management Software And Platforms
  • Services
  • 6.2. Global Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Handheld Devices
  • Wearable Devices
  • 6.3. Global Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self And Home Healthcare
  • Hospitals And Specialty Diabetes Clinics
  • Other End Users
  • 6.4. Global Digital Diabetes Management Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitors (CGMs)
  • Blood Glucose Meters (BGM)
  • Insulin Pumps
  • Smart Insulin Pens
  • Diabetes Testing Strips
  • 6.5. Global Digital Diabetes Management Market, Sub-Segmentation Of Application, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes Management Apps
  • Lifestyle And Diet Management Apps
  • Glucose Tracking Apps
  • Insulin Dose Adjustment Apps
  • Exercise And Activity Tracking Apps
  • 6.6. Global Digital Diabetes Management Market, Sub-Segmentation Of Data Management Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based Diabetes Management Platforms
  • Data Analytics Platforms
  • Electronic Health Record (EHR) Integrated Systems
  • Patient Management Software
  • Remote Monitoring Software
  • 6.7. Global Digital Diabetes Management Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Telemedicine And Virtual Consultation Services
  • Remote Monitoring Services
  • Diabetes Education Services
  • Diabetes Coaching And Support Services
  • Clinical Decision Support Services

7. Digital Diabetes Management Market Regional And Country Analysis

  • 7.1. Global Digital Diabetes Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Digital Diabetes Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Diabetes Management Market

  • 8.1. Asia-Pacific Digital Diabetes Management Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Diabetes Management Market

  • 9.1. China Digital Diabetes Management Market Overview
  • 9.2. China Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Diabetes Management Market

  • 10.1. India Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Diabetes Management Market

  • 11.1. Japan Digital Diabetes Management Market Overview
  • 11.2. Japan Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Diabetes Management Market

  • 12.1. Australia Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Diabetes Management Market

  • 13.1. Indonesia Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Diabetes Management Market

  • 14.1. South Korea Digital Diabetes Management Market Overview
  • 14.2. South Korea Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Diabetes Management Market

  • 15.1. Western Europe Digital Diabetes Management Market Overview
  • 15.2. Western Europe Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Diabetes Management Market

  • 16.1. UK Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Diabetes Management Market

  • 17.1. Germany Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Diabetes Management Market

  • 18.1. France Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Diabetes Management Market

  • 19.1. Italy Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Diabetes Management Market

  • 20.1. Spain Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Diabetes Management Market

  • 21.1. Eastern Europe Digital Diabetes Management Market Overview
  • 21.2. Eastern Europe Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Diabetes Management Market

  • 22.1. Russia Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Diabetes Management Market

  • 23.1. North America Digital Diabetes Management Market Overview
  • 23.2. North America Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Diabetes Management Market

  • 24.1. USA Digital Diabetes Management Market Overview
  • 24.2. USA Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Diabetes Management Market

  • 25.1. Canada Digital Diabetes Management Market Overview
  • 25.2. Canada Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Diabetes Management Market

  • 26.1. South America Digital Diabetes Management Market Overview
  • 26.2. South America Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Diabetes Management Market

  • 27.1. Brazil Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Diabetes Management Market

  • 28.1. Middle East Digital Diabetes Management Market Overview
  • 28.2. Middle East Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Diabetes Management Market

  • 29.1. Africa Digital Diabetes Management Market Overview
  • 29.2. Africa Digital Diabetes Management Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Digital Diabetes Management Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Digital Diabetes Management Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Diabetes Management Market Competitive Landscape And Company Profiles

  • 30.1. Digital Diabetes Management Market Competitive Landscape
  • 30.2. Digital Diabetes Management Market Company Profiles
    • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Digital Diabetes Management Market Other Major And Innovative Companies

  • 31.1. Ascensia Diabetes Care Holdings AG
  • 31.2. Insulet Corporation
  • 31.3. B. Braun Melsungen AG
  • 31.4. Tandem Diabetes Care Inc.
  • 31.5. LifeScan Inc.
  • 31.6. AgaMatrix Inc.
  • 31.7. Glooko Inc.
  • 31.8. DarioHealth Corp
  • 31.9. One Drop
  • 31.10. Dottli Oy
  • 31.11. Ypsomed Holding AG
  • 31.12. ARKRAY Inc.
  • 31.13. ACON Laboratories Inc.
  • 31.14. Becton, Dickinson and Company
  • 31.15. Care Innovations LLC

32. Global Digital Diabetes Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Diabetes Management Market

34. Recent Developments In The Digital Diabetes Management Market

35. Digital Diabetes Management Market High Potential Countries, Segments and Strategies

  • 35.1 Digital Diabetes Management Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Digital Diabetes Management Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Digital Diabetes Management Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer